Thyroid Drug Recall Most Serious; GLP-1s and Vitamin Deficiency; New T1D Guidelines

(MedPage Today) -- The FDA designated Vitruvias Therapeutics' recall of a lot of 30-mg levothyroxine-liothyronine tablets (Thyroid Tablets) as Class I, its most serious classification. (USA Today) At least six major U.S. hospitals have shut down...